Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Jon Spechler

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Surgical Oncology Clinics of North America|June 9, 2009
Endoscopic therapy in Barrett's esophagus: when and how?Stuart Jon Spechler, Raquel Davila
The American Journal of Gastroenterology|May 10, 2003
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkersCarmela P Morales, Stuart Jon Spechler
Digestive Diseases and Sciences|March 19, 2010
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitisJohn William Jacobs, Stuart Jon Spechler
Gastrointestinal Endoscopy Clinics of North America|November 20, 2020
Advances in Biomarkers for Risk Stratification in Barrett's EsophagusRhonda F Souza, Stuart Jon Spechler
The American Journal of Gastroenterology|April 11, 2012
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic reviewKerry B Dunbar, Stuart Jon Spechler
The American Journal of Gastroenterology|August 8, 2009
Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis?Shehzad Nawaz Merwat, Stuart Jon Spechler
Mayo Clinic Proceedings|May 29, 2014
Controversies in Barrett esophagusKerry B Dunbar, Stuart Jon Spechler
The American Journal of Gastroenterology|October 14, 2018
Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?Stuart Jon Spechler, Vani Konda, Rhonda Souza
Gastroenterology Clinics of North America|May 13, 2014
Eosinophilic esophagitis: interactions with gastroesophageal reflux diseaseEdaire Cheng, Rhonda F Souza, Stuart Jon Spechler
Digestive Diseases and Sciences|March 28, 2012
Sorafenib for treatment of hepatocellular carcinoma: a systematic reviewBingru Xie, David H Wang, Stuart Jon Spechler
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Surgical Oncology Clinics of North America|June 9, 2009
Endoscopic therapy in Barrett's esophagus: when and how?Stuart Jon Spechler, Raquel Davila
The American Journal of Gastroenterology|May 10, 2003
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkersCarmela P Morales, Stuart Jon Spechler
Digestive Diseases and Sciences|March 19, 2010
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitisJohn William Jacobs, Stuart Jon Spechler
Gastrointestinal Endoscopy Clinics of North America|November 20, 2020
Advances in Biomarkers for Risk Stratification in Barrett's EsophagusRhonda F Souza, Stuart Jon Spechler
The American Journal of Gastroenterology|April 11, 2012
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic reviewKerry B Dunbar, Stuart Jon Spechler
The American Journal of Gastroenterology|August 8, 2009
Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis?Shehzad Nawaz Merwat, Stuart Jon Spechler
Mayo Clinic Proceedings|May 29, 2014
Controversies in Barrett esophagusKerry B Dunbar, Stuart Jon Spechler
The American Journal of Gastroenterology|October 14, 2018
Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?Stuart Jon Spechler, Vani Konda, Rhonda Souza
Gastroenterology Clinics of North America|May 13, 2014
Eosinophilic esophagitis: interactions with gastroesophageal reflux diseaseEdaire Cheng, Rhonda F Souza, Stuart Jon Spechler
Digestive Diseases and Sciences|March 28, 2012
Sorafenib for treatment of hepatocellular carcinoma: a systematic reviewBingru Xie, David H Wang, Stuart Jon Spechler
Pageof 7